Fairfield Financial Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-285
Closed -$41.2K 130
2024
Q4
$41.2K Hold
285
0.01% 134
2024
Q3
$46.2K Sell
285
-28
-9% -$4.46K 0.02% 145
2024
Q2
$45.7K Buy
+313
New +$46.6K 0.01% 133
2023
Q4
$180K Sell
1,151
-827
-42% -$127K 0.07% 74
2023
Q3
$308K Sell
1,978
-683
-26% -$113K 0.13% 53
2023
Q2
$440K Sell
2,661
-199
-7% -$32.1K 0.18% 48
2023
Q1
$439K Buy
2,860
+1,141
+66% +$184K 0.19% 50
2022
Q4
$304K Buy
1,719
+76
+5% +$13.1K 0.14% 51
2022
Q3
$268K Buy
1,643
+4
+0.2% +$677 0.13% 55
2022
Q2
$291K Sell
1,639
-365
-18% -$65K 0.13% 54
2022
Q1
$355K Buy
+2,004
New +$341K 0.13% 56

Other funds holding JNJ

Fairfield Financial Advisors's JNJ Position: Q1 2025 in Review

Fairfield Financial Advisors sold out of Johnson & Johnson (JNJ) in Q1 2025, closing a stake of 285 shares — an estimated $41.2K sold.

Fairfield Financial Advisors first reported a position in JNJ in Q1 2022 and held it in 11 quarters. The position peaked at $440K in Q2 2023. 4,148 funds tracked by Wall St. Rank hold JNJ as of Q1 2025.

  • Fairfield Financial Advisors reported no remaining Johnson & Johnson position as of Q1 2025 after selling out during the quarter.
  • Fairfield Financial Advisors sold 285 Johnson & Johnson shares in Q1 2025, an estimated $41.2K.
  • Fairfield Financial Advisors first reported a position in Johnson & Johnson in Q1 2022 and held it in 11 quarters.
  • Fairfield Financial Advisors's Johnson & Johnson position peaked at $440K in Q2 2023.
  • 4,148 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2025.

Based on Fairfield Financial Advisors's 13F filing for Q1 2025, filed 9 May 2025.